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The advances made in understanding T cell and anti-
body recognition sites on Ia using monoclonal helper and 
alloreactive T cells are summarized. For many antibod-
ies it has been possible to determine whether the anti-
body recognition site was determined by the a or /3 chain. 
Such defined antibody reagents have allowed the defi-
nition of multiple functional antigen presenting sites on 
a given Ia molecule. Mutant antigen-presenting cells 
independently suggest the existence of such multiple 
functional sites. A detailed analysis of the l-Ab mutant 
bm12 directly defines the chemical nature of one such 
site and suggests that it arose as a result of gene conver-
s ion. Such regions of Ia molecules may be important for 
both T-cell function and antibody-binding. 
The nature of a nt ibody or T -cell recognition sites on Ia 
molecules is poorly defined, even t hough t he complete DNA 
sequences of seve ra l a lle les of t he Ia polypeptides are known 
[1- 5]. In pa rt t his is a refl ection of the problems of studying 
a ny membrane proteins composed of multiple subunits. One 
approach to studying a ntibody sites is to utilize antibodies 
directed against synthetic peptides and find those antibodies 
with the desired binding or biological activity. For Ia molecules 
this approach is _in the preliminary stages. An alternative 
approach is to try to use existing antibody reagents with known 
biological activi ty and cha racterize their reactivity. We will 
present data which characterize ant ibody sites using t his ap-
proach. 
Investigators have utilized several approaches to try to un -
derstand the nature of T -cell recognition sites, including nat-
urally occurring mutations [6- 9], mutant cell lines selected in 
vitro [10], mutants constructed using recombinant DNA tech-
nology [11- 13], a nd monoclonal antibodies to major histocom-
patibility complex (MHC) proteins to block MHC recognition 
by T cells [14- 19]. To study la function, the sole Ia mutant 
mouse strain B .6.C-H-2hmtz (bm12) has proved invaluable [20-
24]. In t his paper we will summarize our current understanding 
of monoclonal a nt ibody and T -cell recognit ion s ites on Ia 
molecules emphasizing the approaches we have taken using T-
cell clones. 
W e have concentrated on T -cell clones which recognize only 
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GAT: poly(L-Glu60, L-Ala30 , L-Tyr 10 
MHC: major histocompatibility complex 
"hybrid" antigens, Ia molecules which are unique to F 1 cells 
[25] . These unique Ia molecules are formed by the combina-
tional association of the a chain from one parent and the {3 
chain from the other parent (Fig 1) . For example, one can 
isolate clones derived from C57BL/6JXA/J (B6XA) F, mice 
which on ly proliferate in response to the synthetic peptide 
poly(L-Glu60, L-Ala30 , L-Tyr10) (GAT) in the presence ofB6XA 
F, cells but not to GAT when presented on either C57BL/6J 
(B6) or A/J (A) strain cells. We have utilized a large panel of 
antibodies to characterize a panel of such F 1 restricted T -cell 
clones. Clones whose proliferation was supported by bm12 x 
B10.A(4R) F 1 cells and whose proliferation was blocked by 
anti-J-Ak antibody 10-2.16 recognized AabA/ molecules. Clones 
which were blocked by antibody Hl16.32 and which did not 
recognize bm12 x B10.A(4R) F, cells utilized a restrict ion site 
on A, kA/ [18,26]. These clones then allow one to try to assess 
the contribution of 1 Ia chain to both antibody-binding and T _ 
cell recognition. 
MONOCLONAL ANTIBODY BINDING CAN BE 
LOCALIZED TO THE a OR {3 CHAIN 
A direct approach of localizing antibody binding is to isolate 
the individual a and {3 chains and simply monitor the precipi-
tation of the isolated material [27] . While this method has the 
virtue of being the most direct and definite, it is a lso laborious. 
Additionally, determinants which are easily destroyed or de-
pend on the presence of another chain, would be lost. N ever-
theless, Kupinski, P lunkett, and Freed [27] have mapped 2 
monoclonal antibody determinants to the {3 chain. They were 
able to assign 10-2.16 and 11-5.2 to t he {3 chain. The monoclonal 
antibody 10.2.16 had previously been mapped to the {3 chain 
[28]. Monoclonal antibodies 40F and 40M also react with the 
{3 chain (J. Freed, personal communication). Using isolated 
chains Kupinski et al [27] were unable to localize either 39F or 
39J. However, these investigators were not able to localize any 
antibody to the a chain. 
It is possible to take advantage of the combinational associ-
ation of the IX and {3 polypeptides of la molecules to localize the 
sites recognized by anti-1-Ak antibodies. This method depends 
on the observation that one could clearly distinguish by t wo-
dimensional gel analysis all the Ia polypeptides from the b and 
k haplotypes and that antibodies used react with the k haplo-
type but not b haplotype molecules. The b haplotype polypep-
tide which coprecipitates with the ak and {3k polypeptides allows 
one to determine whether a given monoclonal antibody reacted 
with the IXk or (3k polypeptide. Thus if an antibody reacted with 
the IXk chain, from (b X k) F 1 extracts it would precipitate 1 IX 
chain and 2 (3 chains. Conversely if it reacts with a {3 chain it 
will precipitate 1 {3 chain, but 2 a chains (Fig 1). We have done 
this type of analysis for 8 monoclonal antibodies a nd the results 
are presented in Table I [18,26,28]. 
The fin al approach to the localization of antibody determi-
na nts to the IX or (3 chains is to utilize T-cell clones as typing 
reagents. Thus one simply monitors the inhibition of prolifer-
ation using a collection of clones whose reactivity has been 
determined previously by their behavior with the bm12 muta-
tion and a panel of monoclonal antibodies whose reactivity h as 
been defined biochemically. Following this reasoning we have 
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FIG 1. Schematic diagrams ofF, hybrid I-A"1• molecules s howing 
immunoprecipitation patterns using monoclonal a ntibodies H116.32 
and 10-2 .16. H116.32 precipitates A,,', A {3•, and Aff" polypeptides; 10-
2.16 precipitates A,,', A,.", and All• polypeptides. Reproduced with 
permission from [26]. 
TABLE I. Chain specificities of monoclonal antibodies 
Chain Localization Method 
Monoclonal lA Apparent. Block-
antibody chain spec ificity Isolated 2·0 ge l ing 
recognized chains coprecipitation T ce ll 
clones 
10.2.16 {3. Ia 17 + + + 
10-3-6 {3. Ja 17 + 
H150-13 (Jk Ia 17 + 
40N {3. Ia 1 + + 
39E (Jk Ia 1 + + 
40M (Jk Ia 1 +" + + 
11-5-2 (Jk Ia 2" + 
40F {3. ? +" + 
BP107 (J" ? + 
98 (J" ? +c 
391 {3" ? +c 
H116-32 a• Ia 19 + + 
39J a• Ja 19 + + 
40J a• Ia 2 + + 
39F a• Ia 2 + + 
H118-49 a• la 2 + 
The determination of Ia chain speci fic ity of monoclonal antibodies 
(+)indicates the method was used to determine chain specificity. Data 
is summarized from our unpublished results and [18,26-28]. Monoclo-
nal antibodies isolation and characterization was described previously 
[29-32]. 
• Personal communication, J . Freed. 
"The Ia- 2 specificity is comple;< [29] and may be the reason that 
different antibodies reacting with the Ia-2 specificity map to different 
Ia chains. 
c The antibodies a lso react with I-E molecules. 
defined a panel ofT-cell clones, one set which recognizes A} Ali" 
and another set which recognizes A .. "A/ (F ig 2). Unknown 
monoclonal antibodies are thus tested to see if they inhibit the 
proliferation of one or the other set of T -cell clones. We have 
performed th is type of ana lysis for a ll the monoclonal antibod-
ies listed in Table 1 (except 11.5.2). In all the cases where it 
was possible to compare, (9/9) this method agreed exactly with 
t he biochemical localization [18,26-28]. We have on this basis 
tentatively mapped two monoclonals wh ich react with both I-
Ek and I-Ah molecules to the /3b chain (antibodies 9B and 391). 
Obviously this method is indirect for chain localization, but 
has the advantage of being rapid and relatively s imple. Further, 
it directly shows that a ll these hybrid molecules are in fact 
util ized by functiona l T cells. 
F tc 2. The blocking pattern of monoclonal anti-I-A• antibodies on 
antigen induced proliferation ofT cell clones as measured by the uptake 
of [3H]thymidine. Inhibition ofT cell prolife ration by antibodies has 
been described previously [18,26]. Solid boxes indicate greater than 
75% inhibition. Stippled boxes indicate 25-75 % inhibition. White boxes 
indicate less t han 25 % inhibition. NT indicate not tested. Data com-
piled from [18,26] and unpublished observations and represent the 
consensus blocking results from several experiments-
TOPOLOGY OF ANTIBODY-BINDING SITES 
In order to gain an insight into the topological relationship 
of antibody binding sites, competitive binding studies have 
been performed for many of the antibodies used in our studies 
[30,33]. In t hese competitive binding studies, one antibody was 
radioactively labeled, mixed with unlabeled antibody present 
in excess, and allowed to react with cells expressing the appro-
priate Ia molecules. Thus if antibodies reacted with sites iden-
tical to or near one another a lower number Qf counts were 
bound, i.e., inhibition was observed. Competitive binding stud-
ies are consistent with the chain localization assignments in 
Table I. The competitive binding studies demonstrated that 
t he antibodies we classify as anti -a chain all fall into one 
cluster while the antibodies we classify as anti-/3 chain antibod-
ies a ll fa ll into another epitope cluster [30]. Another report 
using other monoclonal antibodies which seemed to react with 
the same Ia specificities, suggested t hat Ia-1 and Ia-17 (which 
we classify as {J chain specificities) are close to one another 
topologically but distant from Ia-2 and la-19 (which we classify 
as a chains specificities) [29] which are in turn close to one 
another. 
bm12 STUDIES DEMONSTRATE MULTIPLE 
FUNCTIONAL SITES ON Ia 
The I-Ah mutant mouse B6.C-H-2bon12 and its wild-type coun-
terpart B6 have been used in a variety of studies examining the 
relationships of immune response genes and Ia function. The 
bm12 strain retains many of the immune response gene char-
acteristics of the progenitor strain 86, but has altered respon-
siveness to some antigens [6]. To critically interpret the exper-
iments using this strain it is crucial to know the nature of the 
bm12 mutation. Serologically and genetically the mutation 
mapped to the I-Ab subregion of the H-2 coruplex [20,21 ]. 
Peptide map analyses suggested that A/m 12 polypeptide chain 
was altered while the A a polypeptide from the bm12 strain was 
unchanged [34,35] . DNA sequencing of the A/"'' 2 gene dem-
onstrated 3 nucleotide differences in the NHz terminal or first 
domain when compared to the A/ gene [36,37]. These changes 
were clustered within a stretch of 14 nucleotides corresponding 
to amino acids 67-71 of the mature {J chain polypeptide. This 
provides a /3 chain with precisely defined amino acid substitu-
tions for use in functional studies. 
We have focused on the abi lity of the bm12 strain to serve 
as both an allostimulus for alloreactive T -cell clones and as an 
antigen presenting cell to antigen reactive T-cell clones. In our 
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fi rst series of experimen ts it was found that most of t he alia-
reactive clones which recognized B6 cells did not recognize 
bm12 stimulato r cells. They showed that t he bm12 mutation 
destroyed t he a llostimulation site recogni zed by t hese clones. 
However, 1 clone recognized both bm12 and B6 cells, implying 
t hat t here are at least 2 allorecognit ion s ites on t he I-Ai' 
molecule. Even more surp risingly, among clones specific for t he 
Aa"A8k hybrid molecule, 2 clones were found which recognized 
bm12 cells, although neit her recognized B6 cells. All of t he 
other F ,-restricted clones did not recogni ze eit her B6 or bm12 
cells. One of t hese clones is an alloreactive A anti -B6X A F , 
clone, while t he other is a GAT -reactive clone ofB6XA origin. 
T he ex istence of t hese two diffe rent classes of clones suggests 
t hat t here a re at least 2 sites recognized by T -ce ll sites on t he 
A,}'A/ molecule [38]. H ochman and Huber also find s imilar 
evide nce for multip le functiona l sites on Ia molecules using t he 
bm1 2 mutant and B6 strains and monitoring t heir ability to 
p resent different insulins to primed T cells [39]. 
Whether or not t he sites are prec ise ly where t he mutation 
occurs or in fact a re at a distant s ite whose conformation is 
influenced by t he mu tation is unknown. H owever , it is clear 
t hat t his mutation is cri t ica l to t he formation of t he s ite 
recognized by T ce ll s. 
MONOCLONAL ANTIBODIES DEMONSTRATE 
M ULTIP LE FU NCTIONAL SITES 
Ant ibodies have been used to study l a recogni t ion by T cells. 
T he advent ofT-cell cloning and monoclonal ant ibodies has 
allowed a deta iled system in which to study this in teraction . As 
an example we have used a panel of ant ibodies to inhibi t a 
panel of F , restricted T cell clones. An t ibodies 10.2.16 a nd 
H116-32 distinguished 2 mutually exclusive fa milies (Fig 2). 
One group of clones was inhibi ted by 10.2.16 and not by H116-
32 (G roup l ) and t he other group exhibited reciprocal inhibit ion 
(Group ll ). Within t he H ll6-32 group (G roup II ) t he patte rn 
was complex. In part icula r, monoclona l ant ibodies 40J and 39F 
were clearly di fferen t. In thi s type of ana lysis one might argue 
t hat overlapping or subsetting patterns of inhibition ofT -cell 
clone proli fe ration might s imply refl ect diffe rences in t he rel-
ative affini ty of ant ibodies a nd T ce lls fo r Ia molecules. How-
ever, t hi s cannot expla in t he differen tial blocking seen wi th 
monoclonals 4.0J and 39F . T hese diffe ren ces suggested t hat 
t here were mult iple s ites on t he A} A1, " molecule [26]. A similar 
ana lysis using Ant i-I-E reactive monoclonals and T -cell clones 
show t he sa me type di fferential inhibi to ry effects of monoclonal 
ant ibodies. T hus, t hese results suggest t hat there are mult iple 
fu nctiona l T-ce ll sites on t he 1-Ek molecule [40]. 
Studies wi th 1-Ak mutant cell lines selected in vit ro wit h 
an tibodies suggest t hat there a re mul t iple functional sites on 
t he 1-N molecule [10). In t hese studies some I-Ak restricted T-
cell clones were able to respond to ant ige n on both t he mutant 
and pa rent cell lines whi le othe rs could on ly respond to the 
parent line. T his indicates that one s ite was destroyed by t he 
mutation while t he other site was unaffected. In addi t ion, such 
studies suggested t hat certa in determinants recogni zed by an -
t ibodies tended to be coo rdinately lost, consistent wi th our 
assignments to t he a or {3 chains [10] . 
HYPERVARIABLE REG ION S MAY FUNCTION IN 
ANTIGEN PRESENTAT IO N 
One ve ry in terest ing findin g which a rose from t he sequencing 
of t he I-A cr and I-E (3 genes was t hat t he all elic differences 
were cluste red [5,41] . Different strains of mice, which expressed 
d ifferent alleles, te nded to vary in t he same regions. Us ing t he 
ana logy to im munoglobulins t hese we re termed bype rva riable 
regions 15]. Such regions may also ex ist for t he A ,Bchains, 
t hough there is less sequence data and such regions a re not as 
well defined [3]. Previously, t he abili ty to respond to a va ri ety 
of de fined ant igens (lr ge nes) was mapped in to the I-A or I-E 
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subregions, by ut ilizing recombinan t strains of mice which 
expressed differentIa alleles [19] . Therefore , it was speculated 
t hat these "hypervariable" regions were critical for determining 
immune responsiveness. A prediction of such a model would be 
t hat a lterations in such regions would alter immune respon-
siveness in vivo and in vit ro. 
THE bm12 MUTATION MAY BE THE RESULT OF A 
GENE CONVERSION EVENT 
One striking example of how a functional site can be t reated 
and analyzed arose from the study of t he bm12 mouse. As 
ment ioned previously, t he ent ire sequence of t he bm12 I-A 
chain is known. Because of the nature of the substi t ut ions, it 
has been proposed that these differences a rose from a gene 
conversion event involving the A/ and E pb gene [36,37,42). The 
3 amino acids where A/m 12 differs from A~b are ident ical t o 
those found in E/. These substitutions correspond to one of 
the so-called hypervariable regions of t he E polypept ide 
[41,42]. Even more striking is the finding t hat some T cells 
restricted to I-E region molecules, recognize bm1 2. Hochma n 
and Huber found that B6 mice, which normally do not express 
1-E molecules, did not respond to sheep insulin while other 
strains of mice expressing E / or E / did. Surprisingly, t he 
mutant bm12 stra in also responded a nd could present sheep 
insulin to primed T cells suggesting t hat T cells recognized a 
part of AIJ""'' 2 which "looked like" Etlb [39]. We have desc ribed 
an alloreactive T cell clone, which is restricted to the I-E region 
which recognizes bm1 2 cells bu t not B6 cells [42]. These 
experiments provide direct funct ional ev idence t hat t he bm1 2 
mutation arose from a ge ne conversion event and t hat t his 
event is immunologically relevant. Furt her , t he recogni t ion of 
this region by an alloreactive T-cell clone provides direct evi-
dence of t he importance of "hypervariable" regions in T -cell 
stimulation. Thus not only class I [ 43] but class II [36,37,39,42] 
products can be altered by gene conversion events. 
Gene conversion thus may serve as a mechanism which acts 
on class Ia genes to create sequence diversity over evolutionary 
t ime. If in fact each hypervariable region can independent ly 
fun ction as "antigen binding" or interaction sites, t he presence 
of such mul t iple sites increases the number of ways Ia can 
present ant igen to T cells. 
ANTIBODY BINDING SITES 
One can correlate t he binding of monoclona l an t ibodies with 
the amino ac id sequence predicted by eDNA sequencing studies 
by t he following scheme. Using t he monoclonal an t ibodies 
defin ed as reacting wit h t he a or (3 chains one can take advan-
tage of the strain distribut ion pattern of t he monoclona l an t i-
bodies reactivity. In effect, t he stra ins expressing diffe ren t I-A 
alleles se rved as "mutants" though t hey are complex in t hat 
there a re multip le differences between t he alleles. The most 
DNA sequence data are available for the I-A achains so we 
examined the stra in distribut ion pattern of monoclonals 40J , 
39F, 116-32, and 39J . These ant ibodies all react with k haplo-
type stra ins and not t he d, b, f , u , and q haplotype stra ins. T hus 
as our first approximation, we looked for residues presen t in 
the k haplotype but not in the b, d, [ , and u haplotypes . There 
are 2 such regions, at amino acid posit ions 57 and 65, and we 
suggest that these regions are importan t for binding of these 
ant ibodies. Int riguingly t hese s ites are in t he "hypervariable" 
regions of t he An cha ins which may be important in ant igen 
presentation. It is important to note t his type of ana lysis in 
this case neglects t he cont ribution of t he .B chain. H owever, we 
nonetheless feel it is an important first step . For example, not 
only can one directly test by t ransfection and site-directed 
mutage nesis t he prediction t hat t hese s ites a re important in 
ant ibody binding and T -cell function, but one can specifica lly 
predict exactly which changes should alte r t hose biologic activ-
ities. 
Ult imately one would like to know t he nature of T -cell 
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restriction or functional sites, t he determinants recogni zed by 
antibodies, and t he structura l basis of t hese s ites. A final 
resolut ion of t hese questions may ultimately lie in detailed x-
ray crystallographic a nalysis of t hese molecules. However, t he 
studies summarized here represent important initia l steps in 
characterizing in molecul ar terms t he sites of Ia molecules 
recognized by T cells and ant ibod ies. 
We would like to thank Mindy Palmiere a nd Trisha Petrovick for 
t heir expert ass istance in manusc ript preparation. 
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